Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 31, 1998

Primary Completion Date

September 30, 2001

Study Completion Date

June 30, 2005

Conditions
Breast CancerOvarian Cancer
Interventions
PROCEDURE

Genetic Counseling

Two visits with a specially trained genetic counselor or nurse in conjunction with a medical oncologist and/or a medical specialist will be done in which information will be given either about genetic counseling or enhanced informed consent. These visits will be audio-taped to monitor how the project staff is covering the important information about testing.

PROCEDURE

Informed Consent Counseling

Two visits with a specially trained genetic counselor or nurse in conjunction with a medical oncologist and/or a medical specialist will be done in which information will be given either about genetic counseling or enhanced informed consent. These visits will be audio-taped to monitor how the project staff is covering the important information about testing.

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Medical University of South Carolina

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT00165152 - Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing | Biotech Hunter | Biotech Hunter